Cadila to file seven drug master files with US FDA
Cadila Pharmaceuticals (CPL) has decided to strengthen its international operations and is planning to file seven more drug master files (DMFs) with US FDA for selling its active pharmaceutical
Cadila Pharmaceuticals (CPL) has decided to strengthen its international operations and is planning to file seven more drug master files (DMFs) with US FDA for selling its active pharmaceutical